Skip to main content
TipRanks
Go Ultimate75% OFF

Itaconix (ITX) Q2 2026 Earnings Report

3 Followers

GB:ITX Q2 2026 EPS Results

Actual EPS
-GBP 0.02
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-GBP 0.03

GB:ITX Q2 2026 Revenue Results

Actual Revenue
GBP 6.16M
Expected Revenue
GBP 6.17M
Beat/Miss
Missed by -GBP 9,690.996
YoY Revenue Growth
+65.73%

Earnings Announcement Details

Quarter
Q2 2026
Date
09/08/2026
Time
Before Open
Conference Call
Tuesday, September 8, 2026
GB:ITX Upcoming Earnings

Itaconix's next earnings date is estimated for March 30, 2027, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:Sep 08, 2026|% Change Since:-5.80%|
Earnings Call Sentiment|Positive

The call was strongly optimistic, supported by record first-half revenue, 72% half-over-half growth, a 166% increase in EMEA revenue, stable 36% gross margins, first-time adjusted EBITDA break-even, expanding customer adoption, and a strong cash position. Management also described substantial opportunities in detergents, paints, and crops and outlined a path toward $30 million of revenue in three to four years. The main challenges were higher administrative expenses, reliance on reorders and additional customer wins, China-only itaconic acid supply, tariff and shipping volatility, and several emerging applications that remain in development or have not yet produced consistent reorders.

Company Guidance

Guidance included achieving 600 million unit dose detergent pods in North America in 2026, exceeding $14.8 million in revenues in the second half of 2026 with clear EBITDA profitability, and achieving a small positive EBITDA for the full year; the company believes it can reach $30 million in revenues in the next three to four years with its existing U.S. operations and has a true potential of at least $100 million, expects to invest back into working capital $300,000-$400,000, expects firm crop evaluations by later this year, early next year and, if these go well, expects to scale to at least 10,000 acres next year, expects a final laundry tablet in the next couple of months and said brands may discuss its launch in the first half of 2027, while in paints it expects to be comfortable sometime in 2027.

  • Record Revenue and First EBITDA Break-EvenItaconix delivered record first-half revenue of $8.3 million, up 72% half over half, and achieved adjusted EBITDA break-even for the first time in the company's history, compared with a $200,000 loss in the first half of 2025.
  • Performance Ingredients Revenue More Than DoubledItaconix Performance Ingredients revenue more than doubled to $6.7 million, driven by higher reorder volumes from existing customers and contributions from new customer wins.
  • Gross Profit Growth and Stable MarginsGross profit increased 74% to $3 million, while gross margins remained stable at 36%. Management attributed the stable margins to customer value placed on the polymers and pricing discipline.
  • Fourth Consecutive Half of Revenue GrowthThe company achieved its fourth consecutive half of revenue growth, with North American revenue increasing approximately 29% half over half and EMEA revenue increasing 166%.
  • EMEA Became Approximately Half of Group RevenueEMEA now represents approximately half of group revenue, compared with about one-third in H1 2025, following a new phase of sales-volume takeoff after many years of market development.
  • Customer Expansion and ReordersA significant portion of revenue growth came from existing customers increasing order volumes as their products gained wider distribution and market acceptance. The company also added two new major customers, one in North America and one in EMEA, plus 10 new smaller accounts.
  • New EMEA Customer with Significant Volume PotentialThe company landed a new EMEA customer with the potential to bring in significant volumes. Management is monitoring reorder rates and said it is enthusiastic about the opportunity converting into a customer.
  • Broader Customer and Geographic BaseTwo customers contributed over $1 million each, representing about 40% of first-half revenue, while midsize accounts contributing between $500,000 and $1 million and a wider base of smaller customers continued to develop. Management said the customers are contract manufacturers serving multiple brands, providing additional diversity beyond the headline customer count.
  • North American Unit-Dose ExpansionNorth American revenue grew as the company engaged with more customers to bring tablets and capsules to market. Management expects to achieve its near-term goal of 600 million unit-dose detergent pods in North America in 2026.
  • Cash and Working Capital PositionCash and investments ended the half at $5.1 million, up from $4.4 million at the end of 2025. Working capital was approximately $4.4 million, and management described the company as being in a good cash and working capital position.
  • Existing Facility Supports Medium-Term GrowthManagement said the Stratham facility has all the infrastructure and capacity needed to reach the medium-term $30 million revenue objective and beyond. The company is currently running 24-hour shifts and production three to four days per week, with the ability to increase the number of operating days.
  • High Fixed-Asset TurnoverThe Stratham facility achieved fixed-asset turnover of 15x for the period, which management described as well beyond its peer group. The company expects this metric to continue growing as facility volumes scale.
  • Operational Improvements with Limited CapExThe company continued optimizing throughput at Stratham and completed most improvements to date without significant capital expenditure. It also undertook production optimization projects and capital work to develop future applications.
  • Continued Investment in GrowthItaconix continued investing in people, systems, product development, commercial expansion, production capabilities, and operating improvements while achieving EBITDA break-even.
  • Headcount Added to Support GrowthAverage headcount increased from approximately 26 employees to 33 employees, primarily to support manufacturing volumes, new detergent formulations, and development of revenue opportunities in crops and paint.
  • ERP Implementation UnderwayThe company is implementing an ERP system, plans to have it live by the end of 2026, and expects to use it for the full year of 2027.
  • Path to Positive Full-Year EBITDADespite increased administrative expenses and continued investment, management said the company is on track to achieve small positive EBITDA for the full year.
  • Medium-Term $30 Million Revenue ObjectiveManagement believes Itaconix can reach $30 million in revenue within three to four years using its existing U.S. operations. The company said it needs one more large EMEA detergent customer and success with purpose-driven brands in North America to reach that objective.
  • Second-Half Revenue and Profitability TargetFor the second half of 2026, management said the company needs to exceed $14.8 million in revenue and achieve clear EBITDA profitability, supported by reasonable reorder rates from new customers and continued execution.
  • Longer-Term Growth AmbitionManagement said its ambition extends beyond a $30 million company to at least $100 million, with additional growth opportunities in core detergent applications and new products for paints and crops.
  • Dishwashing Tablet InnovationThe company developed and patented an 8-gram dishwashing detergent tablet with no plastic wrapper, high plant-based content, and super-premium performance. It uses 7.7 grams less per dose than the U.S. super-premium market leader. The company has signed its first bulk supply agreement with a major brand.
  • Triple-Chamber Pod InnovationItaconix developed and patented a triple-chamber dishwashing pod with two liquid chambers and one powder chamber. The product uses 3.3 grams less per dose than the U.S. super-premium market leader while delivering the same performance.
  • Laundry Tablet DevelopmentThe company is developing an 8-gram laundry tablet designed to dissolve in cold wash cycles and provide cleaning and odor-control performance. Management expects the final laundry tablet within the next couple of months and believes the product could attract brand discussions when launched in the first half of 2027.
  • Detergent Market OpportunityManagement identified 70 billion annual dishwasher cycles across EMEA, North America, and slightly beyond. The company's plant-based multifunctional scale inhibitor is currently used in less than 4% of those cycles. Its plant-based multifunctional odor neutralizer does not yet register as a fraction of a percentage of laundry cycles.
  • Phosphate Replacement and Product ClaimsThe company's TSI scale-inhibitor polymers are gaining market share as replacements for phosphates, which are increasingly banned because of environmental damage in waterways. Management said the polymers can reduce overall product cost when properly formulated because less polymer is required while maintaining or improving performance.
  • Paint Development ProgressItaconix is developing a safer paint class with no volatile chemical emissions, less toxic ingredients, and higher plant-based content. The company has a patent on its plant-based binder, has filed a patent for the paint formulation, has trademarked the paint name, and is collaborating with a leading paint company. Management said the no-VOC claim is currently being met and expects to be comfortable with an excellent paint sometime in 2027.
  • Crop Trials UnderwayThe company is conducting crop trials on more than 100 acres of row crops across multiple U.S. states. It expects firm evaluations by later this year or early next year and said initial results look good. It is preparing to scale the evaluation to at least 10,000 acres next year.
  • Global Commercial FootprintThe company said its formulations are present throughout Asia-Pacific, the Americas, and Europe, including foot-odor control in India and fabric sprays in China. Global collaborations with Croda in home care and Nouryon in hair styling are helping extend its reach.
  • Regulatory and Intellectual Property ProgressItaconix has full approval for its copolymers in home care in China and obtained International Nomenclature of Cosmetic Ingredients listing for sodium polyitaconate, supporting personal-care applications. Management said it has excellent patent, know-how, and trade-secret coverage, and successfully contested and had a European patent withdrawn that could have sat on top of an existing patent.
  • Supply Chain Mitigation MeasuresThe company maintains raw materials at its site and in third-party warehouses, works closely with suppliers to maintain inventory at multiple locations, uses off-site warehouses for materials and finished goods, and keeps backup equipment for key plant components.

GB:ITX Earnings History

GB:ITX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 30, 20272026 (Q4)―--0.05――
Sep 08, 20262026 (Q2)―-0.02-0.0333.33% (+0.01)
Mar 24, 20262025 (Q4)―-0.05-0.05-12.50% (-0.01)
Sep 15, 20252025 (Q2)―-0.03-0.0650.00% (+0.03)
Mar 31, 20252024 (Q4)―-0.05-0.054.00% (+0.00)
Sep 10, 20242024 (Q2)―-0.060―
Apr 15, 20242023 (Q4)―-0.05-0.1360.63% (+0.08)
Sep 12, 20232023 (Q2)―0.00-0.1100.00% (+0.10)
Jun 05, 20232022 (Q4)―-0.13-0.02-452.17% (-0.10)
Sep 14, 20222022 (Q2)―-0.10-0.02-400.00% (-0.08)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed